Xiaojun Chen, Keqiang Zhang, Ke Wang, Ruifang An, Dong Wang, Dapeng Li, Ying Yang, Chunyan Wang, Xiumin Li, Bingzhong Zhang, Xunqiang Wang, Zhenling Li, Xiaojing Wan. "Benmelstobart plus carboplatin/paclitaxel with or without anlotinib, followed by maintenance benmelstobart with or without anlotinib, as first-line treatment for advanced or recurrent endometrial cancer: A randomized, open-label, phase II trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.5508